Robert Schneider, Ph.D.
Albert Sabin Professor of Molecular Pathogenesis
Department of Microbiology
Associate Director of Translational Research and Co-Director of Breast Cancer Research for the NYU Cancer Institute
Program in Microbiology, Cellular and Molecular Biology, Molecular Oncology and Immunology
direct line: (212) 263-6006

Education and General Information

Graduate Education: Dr. Schneider received his Ph.D. in Biomedical Sciences from Mt. Sinai School of Medicine, New York, NY in 1981.

Postdoctoral Training: Dr. Schneider was a Postdoctoral Research Fellow in the Department of Microbiology at Stony Brook, continued in the Department of Molecular Biology at Princeton University, Princeton. NJ, 1981-1985.

Post-transcriptional regulation of gene expression in breast cancer and the inflammatory response
Dr. Schneider is Director of translational cancer research, Co-director of the breast cancer research program and an Associate Director of the NYU Cancer Institute. His lab focuses on fundamental cellular processes of genetic deregulation which are associated with development of human carcinomas, particularly breast cancer and the control of oncogene and pro-inflammatory cytokine mRNA stability. In these areas of research his investigations are directed to the mechanisms by which regulation of cellular protein synthesis, angiogenesis, hypoxia and control of inflammatory cytokine mRNA stability and translation promote malignant tumor development and regulate the inflammatory response.

Schneider Lab
Medical Science Building
Room 238
550 First Avenue
New York, NY 10016
t: (212) 263-6006
f: (212) 263-8276
e: Robert Schneider